Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eslicarbazepine acetate extension maintenance study in bipolar I disorder
2005-002134-35Phase 2Completed
- Sponsor
- BIAL
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of eslicarbazepine acetate in bipolar I disorder (3 arms), sponsored by BIAL. Started Aug 2005; status: completed.
02
Drugs
eslicarbazepine acetate
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on 2005-002134-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002134-35.